Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
GoodRx Holdings ( (GDRX) ) just unveiled an update.
On October 31, 2025, GoodRx Holdings announced that Trevor Bezdek, Co-Chairman of the Board, will end his employment and executive officer role with the company upon his contract expiration on November 1, 2025. Despite stepping down from his executive position, Bezdek will continue as a non-employee Co-Chairman of the Board, receiving standard compensation and stock awards under the company’s Non-Employee Director Compensation Program.
The most recent analyst rating on (GDRX) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on GoodRx Holdings stock, see the GDRX Stock Forecast page.
Spark’s Take on GDRX Stock
According to Spark, TipRanks’ AI Analyst, GDRX is a Neutral.
GoodRx Holdings shows strong financial performance with improved profitability and cash flow, which is a major positive factor. However, technical indicators suggest a bearish trend, and the valuation appears high. The earnings call provided mixed signals with strong segment growth but also highlighted significant challenges. These factors collectively result in a moderate overall stock score.
To see Spark’s full report on GDRX stock, click here.
More about GoodRx Holdings
GoodRx Holdings, Inc. operates in the healthcare industry, primarily offering services that help consumers access affordable prescription medications. The company focuses on providing cost-saving solutions and price transparency for prescription drugs.
Average Trading Volume: 4,829,759
Technical Sentiment Signal: Sell
Current Market Cap: $1.17B
See more data about GDRX stock on TipRanks’ Stock Analysis page.